Related Experiment Video
Updated: Jun 16, 2026

Isolation and Culture of Primary Mouse Keratinocytes from Neonatal and Adult Mouse Skin
Published on: July 14, 2017
Cell penetrable peptide nucleic acids targeting PDZK1IP1 with anti-inflammatory potential in human keratinocytes
Daram Jung1, Sun Hee Jin2, Yeasel Jeon3
1Natural Products Research Institute, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea; OliPass Corporation, Yongin, Gyeonggi 17015, Republic of Korea.
Abstract:
PDZK1-interacting protein 1 (PDZK1IP1) has emerged as a potential therapeutic target for skin inflammatory diseases and epithelial tumors. This study investigates the modulation of PDZK1IP1 gene expression using peptide nucleic acids (PNAs), a class of oligonucleotide therapeutics known for their robust binding affinity to complementary nucleic acid sequences and their resistance to degradation by nucleases. To enhance water solubility and cellular permeability, modified PNA oligomers were synthesized by conjugating nucleobases with primary amine chains. A study using a fluorescein-labeled modified PNA oligomer demonstrated significantly enhanced cellular permeability in HaCaT cells compared to the unmodified PNA. These modified PNA oligomers effectively suppressed PDZK1IP1 gene expression and alleviated interferon γ (IFNγ)-induced inflammatory responses in normal human keratinocytes. These findings suggest the potential application of modified PNAs targeting PDZK1IP1 in the treatment of skin inflammatory diseases.
Insights
Modified peptide nucleic acids (PNAs) effectively suppressed PDZK1IP1 gene expression, reducing inflammation in skin cells. This offers a promising therapeutic strategy for inflammatory skin diseases.
Area of Science:
- Molecular biology
- Dermatology
- Oligonucleotide therapeutics
Background:
- PDZK1-interacting protein 1 (PDZK1IP1) is implicated in skin inflammatory diseases and epithelial tumors.
- Peptide nucleic acids (PNAs) are known for their high binding affinity and nuclease resistance, making them suitable for therapeutic applications.
Purpose of the Study:
- To investigate the modulation of PDZK1IP1 gene expression using modified PNAs.
- To assess the therapeutic potential of PNAs targeting PDZK1IP1 in skin inflammatory conditions.
Main Methods:
- Synthesis of modified PNA oligomers with enhanced water solubility and cellular permeability via conjugation with primary amine chains.
- Evaluation of cellular permeability of fluorescein-labeled modified PNAs in HaCaT cells.
- Assessment of PDZK1IP1 gene expression suppression and alleviation of interferon γ (IFNγ)-induced inflammatory responses in normal human keratinocytes.
Main Results:
- Modified PNA oligomers demonstrated significantly enhanced cellular permeability in HaCaT cells compared to unmodified PNAs.
- The modified PNAs effectively suppressed PDZK1IP1 gene expression.
- Interferon γ (IFNγ)-induced inflammatory responses in normal human keratinocytes were alleviated by the modified PNAs.
Conclusions:
- Modified PNAs targeting PDZK1IP1 show potential for treating skin inflammatory diseases.
- Enhanced PNA design improves cellular uptake and therapeutic efficacy.
- PDZK1IP1 represents a viable therapeutic target for dermatological conditions.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

